| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 01/04/2007 | WO2007002239A2 Porous beta-tricalcium phosphate and methods for producing the same |
| 01/04/2007 | WO2007001506A1 Composition and method of protection against uv irradiation |
| 01/04/2007 | WO2007001453A2 Glycerin based synthesis of silver nanoparticles and nanowires |
| 01/04/2007 | WO2007000473A1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 01/04/2007 | WO2007000472A1 Self-sterilizing products |
| 01/04/2007 | WO2006120696A3 An improved pharmaceutical composition |
| 01/04/2007 | WO2006014865A3 Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses |
| 01/04/2007 | WO2005097138A3 Combinations comprising oxcarbazepine to treat affective disorders |
| 01/04/2007 | WO2005060979A8 Elemental sulfur as an oral or parentral medical product |
| 01/04/2007 | US20070003637 Bicarbonate-based solutions for dialysis therapies |
| 01/04/2007 | US20070003636 Statins (HMG-COA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 01/04/2007 | US20070003634 biomedical materials; synthetic bone; biocompatability |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003603 Antimicrobial silver compositions |
| 01/04/2007 | US20070003596 Drug depot for parenteral, in particular intravascular, drug release |
| 01/04/2007 | US20070003593 Bone paste |
| 01/04/2007 | US20070003492 Porous silica having substance carried thereon |
| 01/04/2007 | CA2613647A1 Self-sterilizing products comprising a polymer bound to a phthalocyanine derivative |
| 01/04/2007 | CA2613086A1 Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles |
| 01/04/2007 | CA2612674A1 Non-irritating cosmetic or dermatological compositions |
| 01/04/2007 | CA2612582A1 Compositions and methods for producing a salty taste in foods or beverages |
| 01/04/2007 | CA2587314A1 Glycerin based synthesis of silver nanoparticles and nanowires |
| 01/03/2007 | EP1738750A1 Method of granulating calcium carbonate and products provided therefrom |
| 01/03/2007 | EP1737537A1 Use of simethicone in constipated patients |
| 01/03/2007 | EP1737474A2 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 01/03/2007 | EP1737473A2 Lithium combinations, and uses related thereto |
| 01/03/2007 | EP1737470A2 Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
| 01/03/2007 | EP1737439A2 Calcium salts for the treatment of psoriasis, dermatitis and dandruff |
| 01/03/2007 | EP1633394B1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1452254B1 Preparation of metallic nanoparticle with shell-crosslinked micelle as mold |
| 01/03/2007 | EP1448771B1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1192184B1 Surfactant protein c esters |
| 01/03/2007 | CN1889983A Silver coatings and methods of manufacture |
| 01/03/2007 | CN1889943A Synergistic anti-cancer compounds |
| 01/03/2007 | CN1889843A Pharmaceutical composition, methods of obtaining and use thereof |
| 01/03/2007 | CN1889829A Antimicrobial compositions comprising polymeric stabilizers |
| 01/03/2007 | CN1889828A Composition and process for coloring and preserving wood |
| 01/03/2007 | CN1887877A Thirteen-eliment nanometer RE anticancer compound and its prepn and application |
| 01/03/2007 | CN1887876A Nanometer RE heterocyclic anticancer compound and its prepn and application |
| 01/03/2007 | CN1887717A Nanometer binary anticancer RE compound and its prepn and application |
| 01/03/2007 | CN1887352A Composition for treating eye's fungal and bacterial infection |
| 01/03/2007 | CN1887335A Tumor-inhibiting anticancer oral liquid |
| 01/03/2007 | CN1887334A Cathartic medicine composition |
| 01/03/2007 | CN1887331A Fracture setting medicine powder |
| 01/03/2007 | CN1887329A Bagged Chinese medicine for hot compress of intervertebral disc and its prepn process |
| 01/03/2007 | CN1887313A Chinese medicine composition for treating male's sterility and its prepn |
| 01/03/2007 | CN1887308A Medicine for treating tinea manuum and tinea pedis and prepn of medicine cream |
| 01/03/2007 | CN1887299A Pus drawing out ointment of pearl and cunxiang |
| 01/03/2007 | CN1887295A Medicine for promoting healing of wound |
| 01/03/2007 | CN1887294A Orally taken liquid medicine composition containing strontium |
| 01/03/2007 | CN1887257A Anticancer medicine composition of platinum compound and clorfarabine |
| 01/03/2007 | CN1293047C Aminoacetonitriles derivant for controlling parasite |
| 01/03/2007 | CN1292802C Therapeutical solution for nuring wound and dressing material used with the theraputical solution |
| 01/03/2007 | CN1292758C Paste for treating premature ejaculation |
| 01/03/2007 | CN1292756C Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method |
| 01/02/2007 | US7157614 Layer of polymeric gel block copolymer and mineral oil, and a second layer containing bactericidal silver metal in nylon fabric; dentistry, periodontal disease; appliances for mouth, nose, or other body cavity; bite blocks or plates, caps, braces |
| 01/02/2007 | US7157079 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/02/2007 | CA2265926C Method of altering plasma homocysteine levels in humans |
| 01/02/2007 | CA2225628C Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 12/28/2006 | WO2006138372A2 Methods and reagents for the treatment of inflammatory disorders |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006135965A1 Composition for treating skin lesions |
| 12/28/2006 | WO2006091767A3 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors |
| 12/28/2006 | WO2006088487A3 Permanently linked, magnetic chains |
| 12/28/2006 | WO2006041409A8 Medical solution, method for producing and use thereof |
| 12/28/2006 | WO2006031191A8 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 12/28/2006 | WO2005123192A3 Improving pain treatment with strontium combinations |
| 12/28/2006 | US20060293323 Therapeutic Combinations of erb B Kinase Inhibitors and Antineoplastic Therapies |
| 12/28/2006 | US20060293265 Methods involving aldose reductase inhibitors |
| 12/28/2006 | US20060293264 STAT3 decoy oligonucleotides and uses therefor |
| 12/28/2006 | US20060292245 Pain relief compositions |
| 12/28/2006 | US20060292244 Use of pvp-iodine liposomes for treatment of acne |
| 12/28/2006 | US20060292243 Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases |
| 12/28/2006 | US20060292242 Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms |
| 12/28/2006 | US20060292241 Processed water and therapeutic uses thereof |
| 12/28/2006 | US20060292240 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292239 Oxygen-enriched microstructured water; reduce changes in blood oxygen saturation levels of a mammal undergoing stress such as exercise |
| 12/28/2006 | US20060292238 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292237 Nutraceutical; drinking water treated with electrolysis, oxygenation; negative oxidation reduction potential; topically suspended in a gel, cream, suspension, ointment, lotion; orally, buccally, sublingually, parenterally, intramuscularly, intravenously; region infected with anaerobic organisms |
| 12/28/2006 | US20060292236 Processed water and therapeutic uses thereof |
| 12/28/2006 | US20060292235 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292234 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292233 Oxygen-enriched microstructured water; treating infections |
| 12/28/2006 | US20060292232 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292231 Microstructured water having reduced oxidation reduction potential compared to double distilled water; oxygen-enriched microstructured water; address pulmonary deficiencies in humans or horses |
| 12/28/2006 | US20060292230 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292229 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292228 Composition and therapeutic uses thereof |
| 12/28/2006 | US20060292220 Compositions and methods for nutrition supplementation |
| 12/28/2006 | US20060292217 Nutritional supplement and soft gelatin capsule delivery system |
| 12/28/2006 | US20060292200 Porous beta-tricalcium phosphate and methods for producing the same |
| 12/28/2006 | US20060292198 implanting matrix for bioactive material which is biocompatible porous forms of beta -tricalcium phosphate granules support the development of new bone throughout its structural form, together with bone morphogenic protein as bioactive material |
| 12/28/2006 | US20060292196 Formulation for obtaining a pharmaceutical composition, method for obtaining and use thereof |
| 12/28/2006 | US20060292158 Method for the treatment of cancer using a novel pharmaceutical composition containing at least one dolastatin 10 derivative |
| 12/28/2006 | US20060292094 Composition and method of protection against UV irradiation |
| 12/28/2006 | DE102005008299A1 Cosmetic and/or dermatological formulation, useful as e.g. antiseptic, comprises metallic silver as active agent, auxiliary- and basic- materials |
| 12/28/2006 | CA2613297A1 Composition for treating skin lesions |